LATETRA

This brand name is authorized in Nigeria.

Active ingredients

The drug LATETRA contains one active pharmaceutical ingredient (API):

1	Tetracycline UNII P6R62377KV - TETRACYCLINE HYDROCHLORIDE
	Tetracyclines are taken up into sensitive bacterial cells by an active transport process. Once within the cell they bind reversibly to the 30S subunit of the ribosome, preventing the binding of aminoacyl transfer RNA and inhibiting protein synthesis and hence cell growth.
	Read more about Tetracycline

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-4442	Capsule	Latetra Capsule CAP 250 mg 10 x 10's (in PVC blisters)	Capsule Red and yellow colored hard gelatin capsules, having printed with “LATETRA” on cap, and “250” on body, containing light yellow powder	02/12/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01AA07	Tetracycline	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01A Tetracyclines → J01AA Tetracyclines
Discover more medicines within J01AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-4442